Skip to main content

Denmark

Buy Article:

$44.00 plus tax (Refund Policy)

Abstract:

Denmark is one of the stronger OECD members on a number of science and innovation indicators. It has a modern open market economy featuring a hightechnology agricultural sector and a sophisticated manufacturing industry, with world leaders in pharmaceuticals, maritime shipping and renewable energy. It has a large government R&D budget and high expenditure on biotechnology and pharmaceutical R&D. In 2008, Denmark's gross domestic expenditure on R&D (GERD) was 2.7% of GDP, firmly above the OECD average of 2.3%. Industry‐financed GERD increased to 61%, while government‐funded GERD declined to 25%. Business expenditure on R&D (BERD) was a comparatively high 1.9% of GDP in 2008; as a percentage of industry value added, this was almost double the OECD average. In that year, Denmark also had a high venture capital intensity of 0.16%, well above the average.

Document Type: Review Article

Publication date: December 1, 2010

oecd/16080270/2010/00002010/00000014/9210051ec015
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more